Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exanthema | 2 | 2024 | 68 | 1.720 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 183 | 1.370 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2021 | 315 | 1.190 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 164 | 0.820 |
Why?
|
| Airway Extubation | 1 | 2023 | 67 | 0.800 |
Why?
|
| Infant, Premature, Diseases | 2 | 2021 | 239 | 0.770 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 79 | 0.740 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 42 | 0.720 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 142 | 0.660 |
Why?
|
| Infant, Newborn | 11 | 2024 | 8082 | 0.650 |
Why?
|
| Infant Mortality | 2 | 2021 | 174 | 0.630 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 174 | 0.630 |
Why?
|
| Infant, Premature | 6 | 2023 | 800 | 0.590 |
Why?
|
| Premature Birth | 1 | 2021 | 380 | 0.570 |
Why?
|
| Puerperal Infection | 1 | 2015 | 8 | 0.510 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 422 | 0.510 |
Why?
|
| Developing Countries | 1 | 2015 | 269 | 0.430 |
Why?
|
| Prenatal Care | 1 | 2015 | 340 | 0.400 |
Why?
|
| Neonatal Sepsis | 2 | 2020 | 29 | 0.340 |
Why?
|
| Amino Acids | 2 | 2012 | 661 | 0.340 |
Why?
|
| Pregnancy | 6 | 2021 | 7072 | 0.320 |
Why?
|
| Vitamin A | 1 | 2013 | 57 | 0.220 |
Why?
|
| Vitamins | 1 | 2013 | 105 | 0.220 |
Why?
|
| Humans | 13 | 2024 | 121732 | 0.210 |
Why?
|
| Infant | 4 | 2024 | 12268 | 0.210 |
Why?
|
| Vascular Malformations | 1 | 2024 | 79 | 0.210 |
Why?
|
| Sirolimus | 1 | 2024 | 221 | 0.200 |
Why?
|
| Pancreas | 1 | 2012 | 213 | 0.200 |
Why?
|
| Sheep | 1 | 2012 | 210 | 0.190 |
Why?
|
| Birth Weight | 1 | 2023 | 333 | 0.190 |
Why?
|
| Indomethacin | 1 | 2021 | 84 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 143 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 234 | 0.190 |
Why?
|
| Glucose | 2 | 2012 | 876 | 0.190 |
Why?
|
| Nitric Oxide | 1 | 2013 | 438 | 0.180 |
Why?
|
| Machine Learning | 1 | 2023 | 203 | 0.180 |
Why?
|
| Leucine | 1 | 2012 | 311 | 0.180 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2020 | 309 | 0.180 |
Why?
|
| Dexamethasone | 1 | 2021 | 274 | 0.170 |
Why?
|
| Morbidity | 1 | 2021 | 239 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2013 | 457 | 0.170 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 38 | 0.170 |
Why?
|
| Drug Utilization | 1 | 2020 | 157 | 0.160 |
Why?
|
| Malawi | 1 | 2020 | 389 | 0.160 |
Why?
|
| Fetus | 1 | 2012 | 580 | 0.160 |
Why?
|
| Insulin | 1 | 2012 | 1190 | 0.150 |
Why?
|
| Female | 8 | 2021 | 64469 | 0.140 |
Why?
|
| Gestational Age | 1 | 2021 | 1112 | 0.140 |
Why?
|
| Sepsis | 1 | 2020 | 471 | 0.130 |
Why?
|
| Organ Size | 2 | 2012 | 411 | 0.100 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 540 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 15610 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 9673 | 0.070 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 28 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2013 | 233 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 177 | 0.050 |
Why?
|
| Animals, Inbred Strains | 1 | 2012 | 5 | 0.050 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2012 | 4 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 17 | 0.050 |
Why?
|
| Solutions | 1 | 2012 | 65 | 0.050 |
Why?
|
| Electrolytes | 1 | 2012 | 51 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2012 | 52 | 0.050 |
Why?
|
| Glucagon | 1 | 2012 | 187 | 0.050 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2012 | 7 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2012 | 75 | 0.050 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2012 | 19 | 0.050 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2012 | 29 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 81 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 1 | 2012 | 59 | 0.050 |
Why?
|
| Random Allocation | 1 | 2012 | 416 | 0.050 |
Why?
|
| Risk | 1 | 2013 | 743 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2012 | 146 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2012 | 382 | 0.050 |
Why?
|
| Hormones | 1 | 2012 | 189 | 0.050 |
Why?
|
| Male | 3 | 2020 | 59115 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 442 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 274 | 0.050 |
Why?
|
| Arginine | 1 | 2012 | 303 | 0.050 |
Why?
|
| Child | 1 | 2021 | 24035 | 0.040 |
Why?
|
| Kinetics | 1 | 2012 | 1317 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 512 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2012 | 1102 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 228 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2012 | 632 | 0.040 |
Why?
|
| Incidence | 1 | 2013 | 2985 | 0.030 |
Why?
|
| Animals | 2 | 2012 | 33662 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3524 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2378 | 0.020 |
Why?
|